Nivolumab for Metastatic Cutaneous Squamous Cell Carcinoma

Nivolumab is a programmed death receptor 1 (PD-1) inhibitor. It is part of a group of drugs known as immune checkpoint blockers, which enable potent and durable T-cell responses against several tumors. We report the case of a patient with a metastatic squamous cell carcinoma, who is being treated wi...

Descripción completa

Detalles Bibliográficos
Autores principales: Oro-Ayude, Marcos, Suh-Oh, Hae Jin, Sacristán-Santos, Victor, Vázquez-Bartolomé, Patricia, Flórez, Ángeles
Formato: Online Artículo Texto
Lenguaje:English
Publicado: S. Karger AG 2020
Materias:
Single Case
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7315375/
https://www.ncbi.nlm.nih.gov/pubmed/32595466
http://dx.doi.org/10.1159/000505478

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7315375/
https://www.ncbi.nlm.nih.gov/pubmed/32595466
http://dx.doi.org/10.1159/000505478

Ejemplares similares